Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2016, Article ID 5120831, 8 pages
http://dx.doi.org/10.1155/2016/5120831
Research Article

Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection

1Hospital del Mar, Infectious Diseases, Barcelona, Spain
2Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
3Hospital del Mar, Internal Medicine, Barcelona, Spain

Received 19 February 2016; Revised 20 May 2016; Accepted 9 August 2016

Academic Editor: Robert R. Redfield

Copyright © 2016 Elisabet Lerma-Chippirraz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Pinzone, M. di Rosa, M. Malaguarnera et al., “Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 9, pp. 1218–1232, 2013. View at Google Scholar · View at Scopus
  2. J.-P. Viard, J.-C. Souberbielle, O. Kirk et al., “Vitamin D and clinical disease progression in HIV infection: Results from the EuroSIDA Study,” AIDS, vol. 25, no. 10, pp. 1305–1315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. N. J. Mueller, C. A. Fux, B. Ledergerber et al., “High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients,” AIDS, vol. 24, no. 8, pp. 1127–1134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. U. C. Bang, S. A. Shakar, M. F. Hitz et al., “Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: A Descriptive Cross-Sectional Study,” Scandinavian Journal of Infectious Diseases, vol. 42, no. 4, pp. 306–310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Lerma, M. E. Molas, M. M. Montero et al., “Prevalence and factors associated with vitamin D deficiency and hyperparathyroidism in HIV-infected patients treated in Barcelona,” ISRN AIDS, vol. 2012, Article ID 485307, 5 pages, 2012. View at Publisher · View at Google Scholar
  6. J. H. Arnsten, R. Freeman, A. A. Howard, M. Floris-Moore, Y. Lo, and R. S. Klein, “Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection,” AIDS, vol. 21, no. 5, pp. 617–623, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Stein, M. T. Yin, D. J. McMahon et al., “Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women,” Osteoporosis International, vol. 22, no. 2, pp. 477–487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. E. T. Overton, K. Mondy, T. Bush et al., “Factors associated with low bone mineral density in a large cohort of HIV-infected US adults: baseline results from the SUN study,” in Proceedings of the 14th Conference on Retroviruses and Opportunistic Infections, vol. 836 of abstract 836, Los Angeles, Calif, USA, February 2007.
  9. L. Gazzola, G. M. Bellistri, C. J. Tincati et al., “Association between peripheral T-Lymphocyte activation and impaired bone mineral density in HIV-infected patients,” Journal of Translational Medicine, vol. 11, article 51, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Walker Harris and T. T. Brown, “Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies,” Journal of Infectious Diseases, vol. 205, no. 3, pp. S391–S398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. W. G. Powderly, “Osteoporosis and bone health in HIV,” Current HIV/AIDS Reports, vol. 9, no. 3, pp. 218–222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Bikle, “Non classic actions of vitamin D,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, pp. 26–34, 2009. View at Google Scholar
  13. T. Ansemant, S. Mahy, C. Piroth et al., “Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients,” BMC Infectious Diseases, vol. 13, no. 1, article 7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Conesa-Botella, C. Mathieu, R. Colebunders et al., “Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?” AIDS Research and Therapy, vol. 6, article 4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al., “Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 1911–1930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. B. W. Hollis, “Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D,” The Journal of Nutrition, vol. 135, no. 2, pp. 317–322, 2005. View at Google Scholar · View at Scopus
  17. C. Brot, P. Vestergaard, N. Kolthoff, J. Gram, A. P. Hermann, and O. H. Sørensen, “Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone,” British Journal of Nutrition, vol. 86, no. 1, pp. S97–S103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Lenders, H. A. Feldman, E. Von Scheven et al., “Relation of body fat indexes to vitamin D status and deficiency among obese adolescents,” American Journal of Clinical Nutrition, vol. 90, no. 3, pp. 459–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Blum, G. Dolnikowski, E. Seyoum et al., “Vitamin D 3 in fat tissue,” Endocrine, vol. 33, no. 1, pp. 90–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Yin and E. Stein, “The effect of antiretrovirals on vitamin D,” Clinical Infectious Diseases, vol. 52, no. 3, pp. 406–408, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Pasquet, N. Viget, F. Ajana et al., “Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use?” AIDS, vol. 25, no. 6, pp. 873–874, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Conesa-Botella, E. Florence, L. Lynen, R. Colebunders, J. Menten, and R. Moreno-Reyes, “Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen,” AIDS Research and Therapy, vol. 7, article 40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Wohl, M. Doroana, C. Orkin et al., “Change in vitamin D levels smaller and risk of development of severe vitamin D deficiency lower among HIV-1-infected, treatment-naive adults receiving TMC278 compared with EFV: 48-week results from the phase III ECHO trial,” in Proceedings of the 18th Conference on Retroviruses and Opportunistic Infections, Boston, Mass, USA, 2011.
  24. T. T. Brown and G. A. McComsey, “Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D,” Antiviral Therapy, vol. 15, no. 3, pp. 425–429, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Welz, K. Childs, F. Ibrahim et al., “Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase,” AIDS, vol. 24, no. 12, pp. 1923–1928, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. R. Pinzone, M. Di Rosa, B. M. Celesia et al., “LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 14, pp. 1938–1950, 2013. View at Google Scholar · View at Scopus
  27. European AIDS Clinical Society, EACS Guidelines, Version 7.1, 2014.
  28. M. F. Holick, “Vitamin D deficiency,” The New England Journal of Medicine, vol. 357, no. 3, pp. 266–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. K. M. Sanders, A. L. Stuart, E. J. Williamson et al., “Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial,” The Journal of the American Medical Association, vol. 303, no. 18, pp. 1815–1822, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Bañón, M. Rosillo, A. Gómez, M. J. Pérez-Elias, S. Moreno, and J. L. Casado, “Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients,” Endocrine, vol. 49, no. 2, pp. 528–537, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. G. El-Hajj Fuleihan, R. Bouillon, B. Clarke et al., “Serum 25-Hydroxyvitamin D levels: variability, knowledge gaps, and the concept of a desirable range,” Journal of Bone and Mineral Research, vol. 30, no. 7, pp. 1119–1133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Ghosn and J.-P. Viard, “Vitamin D and infectious diseases,” Presse Medicale, vol. 42, no. 10, pp. 1371–1376, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Poowuttikul, R. Thomas, B. Hart, and E. Secord, “Vitamin D insufficiency/deficiency in HIV-infected inner city youth,” Journal of the International Association of Providers of AIDS Care, vol. 13, no. 5, pp. 438–442, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. G. L. Colombo, S. Di Matteo, and F. Maggiolo, “Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen,” ClinicoEconomics and Outcomes Research, vol. 5, no. 1, pp. 59–68, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. L. O'Connor, E. M. Gardner, S. B. Mannheimer et al., “Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial,” Journal of Infectious Diseases, vol. 208, no. 1, pp. 40–49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. R. P. Heaney, “The vitamin D requirement in health and disease,” Journal of Steroid Biochemistry and Molecular Biology, vol. 97, no. 1-2, pp. 13–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Dawson-Hughes, R. P. Heaney, M. F. Holick, P. Lips, P. J. Meunier, and R. Vieth, “Estimates of optimal vitamin D status,” Osteoporosis International, vol. 16, no. 7, pp. 713–716, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. R. P. Heaney, M. S. Dowell, C. A. Hale, and A. Bendich, “Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D,” Journal of the American College of Nutrition, vol. 22, no. 2, pp. 142–146, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. Arpadi, D. J. McMahon, E. J. Abrams et al., “Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: A Randomized Clinical Trial,” American Journal of Clinical Nutrition, vol. 95, no. 3, pp. 678–685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Fox, B. Peters, M. Prakash, J. Arribas, A. Hill, and C. Moecklinghoff, “Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial,” AIDS Research and Human Retroviruses, vol. 27, no. 1, pp. 29–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. K. E. Childs, S. L. Fishman, C. Constable et al., “Short communication: inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users,” AIDS Research and Human Retroviruses, vol. 26, no. 8, pp. 855–859, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. E. N. Taylor, G. C. Curhan, and J. P. Forman, “Parathyroid hormone and the risk of incident hypertension,” Journal of Hypertension, vol. 26, no. 7, pp. 1390–1394, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. O. Sahota, M. K. Mundey, P. San, I. M. Godber, N. Lawson, and D. J. Hosking, “The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis,” Bone, vol. 35, no. 1, pp. 312–319, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. T. F. Marques, R. Vasconcelos, E. Diniz, D. Rêgo, L. Griz, and F. Bandeira, “Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat?” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 55, no. 5, pp. 314–317, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al., “Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 7, pp. 1911–1930, 2011. View at Publisher · View at Google Scholar
  46. A. J. Sai, R. W. Walters, X. Fang, and J. C. Gallagher, “Relationship between vitamin D, parathyroid hormone, and bone health,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 3, pp. E436–E446, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. M. M. Rosenvinge, K. Gedela, A. J. Copas et al., “Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency,” Journal of Acquired Immune Deficiency Syndromes, vol. 54, no. 5, pp. 496–499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Daria, C. Laura, R. Elena et al., “Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy?” AIDS, vol. 25, no. 11, pp. 1430–1433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. C. K. Kwan, B. Eckhardt, J. Baghdadi, and J. A. Aberg, “Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New York,” AIDS Research and Human Retroviruses, vol. 28, no. 9, pp. 1025–1032, 2012. View at Google Scholar · View at Scopus
  50. A. Bech, P. Van Bentum, D. Telting, J. Gisolf, C. Richter, and H. De Boer, “Treatment of calcium and vitamin D deficiency in HIV-positive men on tenofovir-containing antiretrovial therapy,” HIV Clinical Trials, vol. 13, no. 6, pp. 350–356, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Klassen, A. R. Martineau, R. J. Wilkinson, G. Cooke, A. P. Courtney, and M. Hickson, “The effect of tenofovir on vitamin D metabolism in HIV-infected adults is dependent on sex and ethnicity,” PLoS ONE, vol. 7, no. 9, article e44845, 2012. View at Publisher · View at Google Scholar · View at Scopus